Stock overview
Rapport Therapeutics, Inc.
Explore the company, reported ownership, price history, and available source evidence.
Rapport Therapeutics, Inc. (RAPP) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $23.40
- · RAPP
- Tracked holders
- 1 fund
- Latest available 13F per fund
RAPP · USD
Price
Close · Nov 18, 2026
- Range low
- $7.15
- Range high
- $52.50
- Observations
- 615
- Session date
- Nov 18, 2026
Jun 7, 2024–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | — | $51,982,224 | 0.25% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market